A new drug combination can double the overall survival for patients with bladder cancer that has spread, a study has found.
Researchers at Barts Health NHS Trust and Queen Mary University found that giving patients enfortumab vedotin and pembrolizum can stop their disease from getting worse and help them live twice as long as those given chemotherapy.